OPTIMER PHARMACEUTICALS INC 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Oct 28, 2013
Insider Transaction Report
Form 4
AMPER LINDA E
SVP, Human Resources
Transactions
- Disposition to Issuer
Stock option (right to buy)
2013-10-24$1.37/sh−100,000$137,000→ 0 totalExercise: $11.41Exp: 2021-01-26→ Common stock (100,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2013-10-24$2.06/sh−30,000$61,800→ 0 totalExercise: $10.72Exp: 2023-02-26→ Common stock (30,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 30, 2013 (the "Merger Agreement"), among Optimer Pharmaceuticals, Inc. ("Optimer"), Cubist Pharmaceuticals, Inc. ("Cubist"), and PDRS Corporation, each option was fully vested and converted into the right to receive a cash payment equal to the excess, if any, of $12.78 (the last reported sale price of a share of Optimer common stock on The NASDAQ Global Select Market on October 23, 2013) over such option's per share exercise price.